Literature DB >> 15823231

Management of poor responders in IVF.

F M Ubaldi1, L Rienzi, S Ferrero, E Baroni, F Sapienza, L Cobellis, E Greco.   

Abstract

Correct controlled ovarian stimulation is of paramount importance in assisted reproductive technologies. Therefore, analysis of the ovarian reserve of the patient is mandatory to tailor the best ovarian stimulation regimen. When the ovarian reserve is reduced, the induction of a multifollicular growth remains a challenge. Several factors could be associated with reduced ovarian response. However, reduced ovarian reserve either in older patients or in young patients represents the most frequent aetiological factor. Whatever is the aetiology, one of the main problems is how to predict a reduced ovarian response, and although several tests have been suggested, no very accurate predictive test is available. A variety of different stimulation protocols have been suggested but the lack of any large-scale, prospective, randomized, controlled trials of the different management strategies and the lack of a uniform definition of the population may result in comparisons of heterogeneous groups of patients, making it difficult to draw any definitive conclusions. Natural cycle IVF may represent an easy and cheap approach in the management of this group of patients. Although no controlled large prospective randomized studies are available to compare the natural IVF procedure with ovarian stimulation IVF in poor responder patients, the efficacy of natural cycle IVF is hampered by high cancellation rates mainly due to untimely LH surge. The use of gonadotrophin-releasing hormone antagonists in the late follicular phase, which reduces the premature LH rise rate, and the improvements in laboratory conditions and fertilization techniques, increase the embryo transfer rates, making this procedure more cost-effective.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823231     DOI: 10.1016/s1472-6483(10)60946-7

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  23 in total

1.  Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study.

Authors:  Ermanno Greco; Katarzyna Litwicka; Cristiana Arrivi; Maria Teresa Varricchio; Daniela Zavaglia; Cecilia Mencacci; Maria Giulia Minasi
Journal:  J Assist Reprod Genet       Date:  2013-11       Impact factor: 3.412

2.  Meta-analysis of GnRH-antagonists versus GnRH-agonists in poor responder protocols.

Authors:  Myrto Papamentzelopoulou; Sofoklis Stavros; Despoina Mavrogianni; Christos Kalantzis; Dimitrios Loutradis; Petros Drakakis
Journal:  Arch Gynecol Obstet       Date:  2021-01-10       Impact factor: 2.344

3.  Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.

Authors:  Kutluk Oktay; Ja Yeon Kim; David Barad; Samir N Babayev
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

4.  Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve.

Authors:  Mario Mignini Renzini; Claudio Brigante; Giovanni Coticchio; Mariabeatrice Dal Canto; Ilaria Caliari; Ruggero Comi; Elena De Ponti; Rubens Fadini
Journal:  J Assist Reprod Genet       Date:  2017-09-04       Impact factor: 3.412

Review 5.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

6.  The assesment of follicular fluid presepsin levels in poor ovarian responder womenandits relationship with the reproductive outcomes.

Authors:  Ali Ovayolu; Özkan Özdamar; İsmet Gün; Cansev Y Arslanbuğa; Tayfun Kutlu; Gülden Tunalı; Ramazan Uluhan
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial.

Authors:  Tansu Kucuk; Hakan Kozinoglu; Ayten Kaba
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

8.  Corifollitropin α followed by menotropin for poor ovarian responders' trial (COMPORT): a protocol of a multicentre randomised trial.

Authors:  Nikolaos P Polyzos; Michel Camus; Joaquin Llacer; Konstantinos Pantos; Herman Tournaye
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

9.  Involvement of single nucleotide polymorphisms in ovarian poor response.

Authors:  Sayyed Mohammad Hossein Ghaderian; Reza Akbarzadeh; Saghar Salehpour
Journal:  J Assist Reprod Genet       Date:  2021-05-29       Impact factor: 3.357

10.  Live birth and cumulative live birth rates in expected poor ovarian responders defined by the Bologna criteria following IVF/ICSI treatment.

Authors:  Joyce Chai; Vivian Chi-Yan Lee; Tracy Wing-Yee Yeung; Hang Wun Raymond Li; Raymond Wun-Hang Li; Pak-Chung Ho; Ernest Hung-Yu Ng
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.